Your browser doesn't support javascript.
loading
Impact of Tofacitinib on Components of the ACR Response Criteria: Post Hoc Analysis of Phase III and Phase IIIb/IV Trials.
Bessette, Louis; Mysler, Eduardo; Kinch, Cassandra D; Kwok, Kenneth; Lukic, Tatjana; On, Phu Vinh; van Vollenhoven, Ronald F.
Affiliation
  • Bessette L; L. Bessette, MD, MSc, Department of Medicine, Laval University, Quebec, Quebec, Canada.
  • Mysler E; E. Mysler, MD, Organización Médica de Investigación, Buenos Aires, Argentina.
  • Kinch CD; C.D. Kinch, PhD, P.V. On, MSc, Pfizer Canada ULC, Kirkland, Quebec, Canada; Cassandra.Kinch@pfizer.com.
  • Kwok K; K. Kwok, MS, T. Lukic, MD, MSc, Pfizer Inc, New York, New York, USA.
  • Lukic T; K. Kwok, MS, T. Lukic, MD, MSc, Pfizer Inc, New York, New York, USA.
  • On PV; C.D. Kinch, PhD, P.V. On, MSc, Pfizer Canada ULC, Kirkland, Quebec, Canada.
  • van Vollenhoven RF; R.F. van Vollenhoven, MD, PhD, Amsterdam Rheumatology and Immunology Center, and Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
J Rheumatol ; 49(6): 566-576, 2022 06.
Article in En | MEDLINE | ID: mdl-35232809

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Rheumatology / Antirheumatic Agents Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Aspects: Patient_preference Limits: Humans Country/Region as subject: America do norte Language: En Journal: J Rheumatol Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Rheumatology / Antirheumatic Agents Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Aspects: Patient_preference Limits: Humans Country/Region as subject: America do norte Language: En Journal: J Rheumatol Year: 2022 Document type: Article Affiliation country: